At the news
? NEUTRALIMPACT 2/10 6-K filed Jun 17, 2026 at 11:30 ET
Genmab filed its updated Articles of Association (June 16, 2026) via a 6-K on June 17, 2026. The document is a routine corporate governance update covering standard provisions on share capital, warrant programs, board composition, and meeting procedures. No material financial, operational, or strategic changes were disclosed.
- Share capital remains DKK 62,353,252 divided into shares of DKK 1 each.
- Board authorized until March 12, 2029 to increase share capital by up to DKK 6,600,000 with or without pre-emption rights.
- Multiple warrant programs for employees (excluding executive management) with caps of DKK 750,000 each under various general meeting authorizations.
- Convertible debt instrument authorization up to DKK 3,000,000 nominal value until March 12, 2029.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access